Rationale – The interaction between two non-psychotropic cannabinoids, cannabidiol (CBD) and cannabigerol (CBG), which have been reported to act as a 5-hydroxytryptamine 1A (5-HT1A) agonist and antagonist, respectively, was evaluated.
Abstract Background Medicinal cannabis registries typically report pain as the most common reason for use. It would be clinically useful to identify patterns of cannabis treatment in migraine and headache,
Please use this link to access this publication. Abstract Rationale When acutely administered intraperitoneally, the non-psychoactive cannabinoid cannabidiol (CBD), its acidic precursor cannabidiolic acid (CBDA) and a stable methyl ester
One thing that has become well-known in the last several years of cannabis research, is that Cannabis Sativa is a very complex plant. Through the on-going discovery of compounds, we
Breast cancer is the most common cancer in women worldwide. Despite advances in early detection, it remains the second leading cause of cancer death in American women, mostly attributed to
Abstract Marijuana is the most commonly abused illicit drug in the United States (US) and much of the Westernized World with a steadily increasing prevalence in usage and abuse
Abstract Cannabidiolic acid (CBDA) is the main phytocannabinoid in fiber and seed-oil hemp (Cannabis sativa L.) plants, but its potential health-related capabilities have been masked for years by a greater
Frequently Asked Questions What is CBD? Cannabidiol, or CBD, is one of at least 80 cannabinoids unique to cannabis. Reported benefits of CBD include being an anti-convulsant, anti-inflammatory, immunosuppressant, anti-emetic,
Glossary This glossary is intended to explain and clarify frequently used terms in our program that people may not be familiar with. Don’t forget to also check out our FAQ page!
It is no new thing that cannabis has been infused in edible products. Dating back to even before Bartolomeo Platina completed the first printed cookbook in the 15th century, where
